WuXi Healthcare Ventures Joins $115M Series E Round In 23andMe

Login to View

Mountain View, California-based DNA testing firm 23andMe, Inc. has completed US$115 million series E financing round led by Fidelity Management & Research Company, with participation from new investors including WuXi Healthcare Ventures.

Continue reading with a China Money Network subscription

Join Now

Already have an account or paid subscription? Log in